Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
AVE-0991 is an agonist of the Mas receptor, also known as the angiotensin (1-7) receptor.1 It binds to the Mas receptor in bovine aortic endothelial cell membranes and COS cells (IC50s = 21 and 47.5 nM, respectively).2,1 It reduces urinary volume in water-loaded mice, an effect that can be blocked by the angiotensin (1-7) antagonist A-779 (Item No. 23396) and is reduced in Mas knockout mice.1 Dietary administration of AVE-0991 (0.58 µmol/kg per day) inhibits perivascular inflammation and increases plaque stability in an ApoE-/- mouse model of atherosclerosis.3 It also inhibits the formation of abdominal aortic aneurysm induced by angiotensin II in ApoE-/- mice.
WARNING This product is not for human or veterinary use.
1. Nonpeptide AVE 0991 is an angiotensin-
2. AVE 0991, a nonpeptide mimic of the effects of angiotensin-
3. Anti-